Similar articles

• Can high-dose immunoglobulin therapy be indicated in neonatal rhesus haemolysis? A successful case of haemolytic disease due to rhesus (c + E) incompatibility.

  Kubo S, Ariga T, Tsuneta H, Ishii T. Kubo S, et al. Eur J Pediatr. 1991 May;150(7):507-8. doi: 10.1007/BF01958434. Eur J Pediatr. 1991. PMID: 1915504
• Plasma exchange in the management of severe rhesus haemolytic disease.

  Halligan A, McGuinness EP. Halligan A, et al. Ir Med J. 1990 Sep;83(3):107-8. Ir Med J. 1990. PMID: 2121660
• Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease.

  Berlin G, Selbing A, Gottvall T. Berlin G, et al. Prog Clin Biol Res. 1990;337:337-40. Prog Clin Biol Res. 1990. PMID: 2112753 No abstract available.
• The introduction of human monoclonal anti-D for therapeutic use.

  Fletcher A, Thomson A. Fletcher A, et al. Transfus Med Rev. 1995 Oct;9(4):314-26. doi: 10.1016/s0887-7963(05)80079-3. Transfus Med Rev. 1995. PMID: 8541714 Review. No abstract available.
• Current status of immunoprophylaxis with anti-D immunoglobin.

  Engelfriet CP, Reesink HW, Judd WJ, Ulander VM, Kuosmanen M, Koskinen S, Rouger P, Morelati F, Tantalo V, Fujii T, de Haas M, van der Schoot CE, Overbeeke M, Koelewijn J, Bonsel G, Vrijkotte T, Zupańska B, Martin-Vega C, Parra Lopez R, de Silva M, Contreras M, Panzer S, Ulm B, Mayr WR. Engelfriet CP, et al. Vox Sang. 2003 Nov;85(4):328-37. doi: 10.1111/j.0042-9007.2003.364_1.x. Vox Sang. 2003. PMID: 14633261 Review. No abstract available.